Building Your Alt Protein Career: Marketing strategy and business development
Event description
Are you interested in working in the alternative protein sector? Join GFI’s academic community coordinator, Asia Sheehab, to learn more about pursuing an academic or industry career in this rapidly growing field. After an overview of opportunities, you’ll hear from Riley Jackson, whose dynamic eight-year career in the alternative protein industry offers valuable insights.
Meet the speaker
Riley Jackson
STRATEGIC PARTNERSHIPS AND MARKETING MANAGER
IVY FARM TECHNOLOGIES
Riley has been a passionate advocate in the alternative protein industry for over eight years. Starting her career in advertising and strategy, she focused on bridging the gap between consumers and their food, highlighting the impact of their choices. Riley was inspired after being part of the Beyond Meat launch into Canada and has since collaborated with innovative companies like the The Good Food Institute, BIOMILQ, and Tindle. On the business development team at Impossible Foods, she successfully launched numerous products into the U.S. market. Determined to transform the global food system, Riley now leads marketing and partnerships at Oxford-based cultivated meat company Ivy Farm Technologies. Her mission is to pave the way for cultivated meat’s market entry and to connect consumers and partners with the possibilities of the future of protein.
Upcoming events
View all events
The Science of Alt Protein: Student research showcase, part 2
Join us for a seminar showcasing outstanding student-led research from GFI’s Academic Research Challenge.
Reporting on food system resilience: The bigger story behind the headlines
New World screwworm, avian flu, prolonged drought, and rising beef prices may seem like separate stories, but together they reveal bigger questions about the resilience of our food system. Join…
Bridge2Food North America
Join GFI at Bridge2Food North America, where food industry leaders will gather to explore the latest developments in ingredient innovation and alternative proteins.
